Partnering OpportunitiesBioTransformations technology provides enhanced specificity to antibody therapy.
The BioTransformations platform technology is capable of controlling the activity of antibodies and other protein based active agents in the body. The technology involves “cloaking” the protein chemically to inhibit its function until required. The active agents are then reactivated at specific sites within the body simply by the administration of light, delivered from available equipment such as dental probes.
This approach increases efficiency and specificity of antibody based therapeutics and can be easily applied to existing monoclonal antibodies.BioTransformations would like to build long term relationships and work together with commercial partners who have antibodies or other protein therapeutics which would benefit from the increased specificity accorded by the cloaking technology.
For further details please contact: